155 related articles for article (PubMed ID: 7942207)
21. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
Jiang N; Zhang RL; Baron BM; Chopp M
J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236
[TBL] [Abstract][Full Text] [Related]
22. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD
Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675
[TBL] [Abstract][Full Text] [Related]
23. Contrasting effects of D- and L-(E)-4-(3-phosphono-2-propenyl)piperazine-2-carboxylic acid as anticonvulsants and as inhibitors of potassium-evoked increases in hippocampal extracellular glutamate and aspartate levels in freely moving rats.
Millan MH; Chapman AG; Meldrum BS
J Neurochem; 1994 Jan; 62(1):217-22. PubMed ID: 7903351
[TBL] [Abstract][Full Text] [Related]
24. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
25. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.
Potschka H; Fedrowitz M; Löscher W
Eur J Pharmacol; 1999 Jun; 374(2):175-87. PubMed ID: 10422758
[TBL] [Abstract][Full Text] [Related]
26. Ischaemic brain damage--prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors.
McCulloch J
Arzneimittelforschung; 1991 Mar; 41(3A):319-24. PubMed ID: 1830483
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
Umemura K; Shimakura A; Nakashima M
Brain Res; 1997 Oct; 773(1-2):61-5. PubMed ID: 9409705
[TBL] [Abstract][Full Text] [Related]
28. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
29. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.
Yang G; Chan PH; Chen SF; Babuna OA; Simon RP; Weinstein PR
Neurosurgery; 1994 Feb; 34(2):339-45; discussion 345. PubMed ID: 8177396
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective properties of aptiganel HCL (Cerestat) following controlled cortical impact injury.
Kroppenstedt SN; Schneider GH; Thomale UW; Unterberg AW
Acta Neurochir Suppl; 1998; 71():114-6. PubMed ID: 9779160
[TBL] [Abstract][Full Text] [Related]
31. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
32. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T
J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454
[TBL] [Abstract][Full Text] [Related]
33. Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.
Eblen F; Löschmann PA; Wüllner U; Turski L; Klockgether T
Eur J Pharmacol; 1996 Mar; 299(1-3):9-16. PubMed ID: 8901001
[TBL] [Abstract][Full Text] [Related]
34. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology.
van Lookeren Campagne M; Verheul JB; Nicolay K; Balázs R
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1011-23. PubMed ID: 7929643
[TBL] [Abstract][Full Text] [Related]
35. Effects of systemic hypothermia and selective brain cooling on ischemic brain damage and swelling.
Park CK; Jun SS; Kim MC; Kang JK
Acta Neurochir Suppl; 1998; 71():225-8. PubMed ID: 9779191
[TBL] [Abstract][Full Text] [Related]
36. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
Shuaib A; Xu Wang C; Yang T; Noor R
Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
[TBL] [Abstract][Full Text] [Related]
37. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate.
Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234
[TBL] [Abstract][Full Text] [Related]
38. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
39. Effect of YM737, a new glutathione analogue, on ischemic brain edema.
Gotoh O; Yamamoto M; Tamura A; Sano K
Acta Neurochir Suppl (Wien); 1994; 60():318-20. PubMed ID: 7976578
[TBL] [Abstract][Full Text] [Related]
40. The effect of non-competitive N-methyl-D-aspartate receptor antagonism on cerebral oedema and cerebral infarct size in the aging ischaemic brain.
Davis M; Perry RH; Mendelow AD
Acta Neurochir Suppl; 1997; 70():30-3. PubMed ID: 9416269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]